Konstantinos Tryfonidis Selected Research

Konstantinos Tryfonidis Research Topics

Disease

16	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2014
11	Neoplasms (Cancer) 11/2023 - 12/2014
2	Triple Negative Breast Neoplasms 11/2023 - 10/2022
2	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2016
2	Infections 01/2018 - 01/2017
1	Pathologic Complete Response 11/2023
1	Carcinoma in Situ 11/2023
1	Heart Arrest (Cardiac Arrest) 01/2018
1	Heart Failure 01/2018
1	Disease Progression 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Frailty 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 01/2018
1	Sudden Death 01/2018
1	Pain (Aches) 01/2018
1	Fatigue 01/2018
1	Cardiotoxicity 01/2017
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017
1	Male Breast Neoplasms (Male Breast Cancer) 01/2017
1	Residual Neoplasm 01/2016

Drug/Important Bio-Agent (IBA)

5	Hormones (Hormone)IBA 10/2021 - 01/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 01/2018
3	Trastuzumab (Herceptin)FDA Link 01/2022 - 01/2017
2	pembrolizumabIBA 11/2023 - 10/2022
2	pertuzumabIBA 01/2022 - 01/2018
2	Capecitabine (Xeloda)FDA Link 10/2021 - 10/2020
2	Estrogen ReceptorsIBA 01/2017 - 08/2016
1	LigandsIBA 11/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022
1	Carboplatin (JM8)FDA LinkGeneric 10/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2022
1	Epirubicin (Ellence)FDA LinkGeneric 10/2022
1	Vinorelbine (Navelbine)FDA LinkGeneric 10/2021
1	eribulin FDA Link 10/2021
1	tetrachloroisophthalonitrile (Bravo)IBA 10/2021
1	niraparibIBA 10/2021
1	Gemcitabine FDA Link 10/2021
1	AnthracyclinesIBA 10/2020
1	Docetaxel (Taxotere)FDA Link 10/2020
1	Ado-Trastuzumab EmtansineIBA 01/2018
1	taxaneIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	abemaciclibIBA 12/2017
1	palbociclibIBA 12/2017
1	ribociclibIBA 12/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2017
1	Bevacizumab (Avastin)FDA Link 02/2017
1	Monoclonal AntibodiesIBA 02/2017
1	AntigensIBA 01/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2017
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	InterferonsIBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 08/2016
1	Gefitinib (Iressa)FDA Link 01/2016
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2016
1	Keratin-19 (Keratin 19)IBA 12/2014
1	Messenger RNA (mRNA)IBA 12/2014

Therapy/Procedure

9	Therapeutics 11/2023 - 07/2016
8	Drug Therapy (Chemotherapy) 11/2023 - 08/2016
5	Adjuvant Chemotherapy 10/2021 - 12/2014
4	Neoadjuvant Therapy 11/2023 - 01/2016
1	Molecular Targeted Therapy 12/2016
1	Immunotherapy 07/2016